Human BMP4 mRNA Encapsulated in Lipid Nanoparticle for Bone and Articular Cartilage Repair in Aged Mice
Source abstract
Abstract
Segmental bone defects and age-related osteoarthritis (OA) are clinically challenging in terms of treatment. Although preclinical studies have demonstrated efficacy for bone defect healing and OA using ex vivo gene therapy or biomaterial sustained-release delivery, few such treatments have translated into clinical therapies due to safety concerns. Bone morphogenetic proteins belong to the transforming growth factor β (TGFβ) superfamily and are effective in bone and cartilage regeneration/repair. Among BMPs, BMP4 is not only effective in promoting bone and cartilage repair but also promotes stem cell renewal potential and exhibits anti-aging effects. Therefore, the aim of this study is to investigate whether human BMP4 mRNA encapsulated in lipid nanoparticles (hBMP4 mRNA/LNP) can promote bone and cartilage repair. In vitro data demonstrated that hBMP4 mRNA/LNP-treated human MSCs secreted BMP4 protein, as detected by ELISA, and enhanced osteogenic differentiation. In vivo results demonstrated that hBMP4 mRNA/LNP at a 50 µg dose promoted limited new bone formation only at 2 weeks after creation of defect in critical-sized calvarial bone defects in aged mice when delivered using fibrin sealant hydrogel, as revealed by micro-CT and histology. However, intra-articular injection (IA) of lower doses (2.5 and 5 µg) in aged mice knee joints prevented cartilage loss, as demonstrated by micro-CT; decreased OARSI histology scores; and improved cartilage-specific matrix COL2. hBMP4 mRNA/LNP at a 5 μg dose significantly increased SOX9+ cells per normalized cartilage area as well as the percentage of SOX9+ cells in the cartilage area. hBMP4 mRNA/LNP treatment showed a trend of pain alleviation and did not change serum hyaluronic acid levels. In conclusion, human BMP4 mRNA encapsulated in lipid nanoparticles improved cartilage repair and delayed cartilage degeneration in aged mice, while having a limited effect on bone healing, even at a higher dosage. These results suggest that hBMP4 mRNA encapsulated with lipid nanoparticles represents a promising treatment for age-related OA.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Osteoarthritis Treatment and Mechanisms · TGF-β signaling in diseases · Angiogenesis and VEGF in Cancer
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Linda and Mitch Hart Center for Regenerative and Personalized Medicine, Steadman Philippon Research Institute, Vail, CO 81657, USA
Laboratory Animal Resources, Colorado State University, Fort Collins, CO 80523, USA
Center for Musculoskeletal Regeneration, Houston Methodist Academic Institute, Houston, TX 77030, USA
Funding
Musculoskeletal Regeneration Partnership Fund by Mary Sue and Michael Shannon and the Donna Giordano Family.
References (57)
Show source-provided references
1. Osteoarthritis10.1016/S0140-6736(19)30417-9 ↗
2. Burden of osteoarthritis in North Africa and Middle East from 1990 to 2021: Findings from the Global Burden of Disease 2021 study10.1007/s10067-025-07761-w ↗
3. Kempny, T., Holoubek, J., Polovko, J., Sedivy, O., Votruba, T., Kachlik, D., and Pilny, J. (2024). Reconstruction of large post-traumatic segmental femoral defects using vascularised bone flaps: A retrospective case series. BMC Musculoskelet. Disord., 25.10.1186/s12891-024-08031-7 ↗
4. The management of critical bone defects: Outcomes of a systematic approach10.1007/s00590-024-04050-1 ↗
5. The induced membrane technique for the management of infected segmental bone defects10.1302/0301-620X.106B6.BJJ-2023-1443.R1 ↗
6. Characterization of the distinct orthotopic bone-forming activity of 14 BMPs using recombinant adenovirus-mediated gene delivery10.1038/sj.gt.3302298 ↗
7. Distinct roles of bone morphogenetic proteins in osteogenic differentiation of mesenchymal stem cells10.1002/jor.20359 ↗
8. The use of heparin/polycation coacervate sustain release system to compare the bone regenerative potentials of 5 BMPs using a critical sized calvarial bone defect model10.1016/j.biomaterials.2022.121708 ↗
9. Comparison of 5 BMPs for their chondrogenic potentials and microfracture-mediated cartilage repair using heparin/PEAD coacervate sustained release polymer
10. Bone morphogenetic proteins 2, 5, and 6 in combination stimulate osteoblasts but not osteoclasts in vitro10.1002/jor.21144 ↗
11. 3D-bioprinting a genetically inspired cartilage scaffold with GDF5-conjugated BMSC-laden hydrogel and polymer for cartilage repair10.7150/thno.38061 ↗
12. Intra-articular therapy with recombinant human GDF5 arrests disease progression and stimulates cartilage repair in the rat medial meniscus transection (MMT) model of osteoarthritis10.1016/j.joca.2016.11.002 ↗
13. Hyaluronic acid hydrogel encapsulated BMP-14-modified ADSCs accelerate cartilage defect repair in rabbits10.1186/s13018-021-02792-w ↗
14. BMP induction of Id proteins suppresses differentiation and sustains embryonic stem cell self-renewal in collaboration with STAT310.1016/S0092-8674(03)00847-X ↗
15. BMP signaling is required for controlling somatic stem cell self-renewal in the Drosophila ovary10.1016/j.devcel.2005.09.013 ↗
16. Functional genomics reveals a BMP-driven mesenchymal-to-epithelial transition in the initiation of somatic cell reprogramming10.1016/j.stem.2010.04.015 ↗
17. BMPs functionally replace Klf4 and support efficient reprogramming of mouse fibroblasts by Oct4 alone10.1038/cr.2010.172 ↗
18. BMP-SMAD-ID promotes reprogramming to pluripotency by inhibiting p16/INK4A-dependent senescence10.1073/pnas.1603668113 ↗
19. BMP4 and Gremlin 1 regulate hepatic cell senescence during clinical progression of NAFLD/NASH10.1038/s42255-022-00620-x ↗
20. Cartilage repair in a rat model of osteoarthritis through intraarticular transplantation of muscle-derived stem cells expressing bone morphogenetic protein 4 and soluble Flt-110.1002/art.24443 ↗
21. Sarsenova, M., Raimagambetov, Y., Issabekova, A., Karzhauov, M., Kudaibergen, G., Akhmetkarimova, Z., Batpen, A., Ramankulov, Y., and Ogay, V. (2022). Regeneration of Osteochondral Defects by Combined Delivery of Synovium-Derived Mesenchymal Stem Cells, TGF-beta1 and BMP-4 in Heparin-Conjugated Fibrin Hydrogel. Polymers, 14.10.3390/polym14245343 ↗
22. Bone morphogenetic protein 4 rescues the bone regenerative potential of old muscle-derived stem cells via regulation of cell cycle inhibitors10.1186/s13287-022-03047-z ↗
23. Force, B.S., Gao, X., and Huard, J. (2026). Protein-Encoding Chemically Modified mRNAs for Musculoskeletal Tissue Regeneration and Repair. J. Funct. Biomater., 17.10.20944/preprints202602.1402.v1 ↗
24. Efficient healing of large osseous segmental defects using optimized chemically modified messenger RNA encoding BMP-210.1126/sciadv.abl6242 ↗
25. A bioactive collagen membrane that enhances bone regeneration10.1002/jbm.b.34275 ↗
26. Transient delivery of modified mRNA encoding TERT rapidly extends telomeres in human cells10.1096/fj.14-259531 ↗
27. Human marrow-derived mesenchymal progenitor cells: Isolation, culture expansion, and analysis of differentiation10.1385/MB:20:3:245 ↗
28. A comparison of bone regeneration with human mesenchymal stem cells and muscle-derived stem cells and the critical role of BMP10.1016/j.biomaterials.2014.04.113 ↗
29. Primer3--new capabilities and interfaces10.1093/nar/gks596 ↗
30. Enhancements and modifications of primer design program Primer310.1093/bioinformatics/btm091 ↗
31. Primer3_masker: Integrating masking of template sequence with primer design software10.1093/bioinformatics/bty036 ↗
32. Quantitative multispectral imaging of Herovici’s polychrome for the assessment of collagen content and tissue remodelling10.1002/term.508 ↗
33. Senolytic treatment for low back pain10.1126/sciadv.adr1719 ↗
34. Osteoarthritis cartilage histopathology: Grading and staging10.1016/j.joca.2005.07.014 ↗
35. Yuan, S., Ruan, G., Wang, X., Lo, G.H., Wang, C., Zhu, Z., Xu, S., Li, W., Cai, X., and Hunter, D.J. (2026). Subchondral bone density and trabecular morphometry mediate the association between knee malalignment and osteophyte progression in osteoarthritis: Data from the osteoarthritis initiative. Clin. Rheumatol., Online ahead of print.10.1007/s10067-026-08067-1 ↗
36. FDA-approved bone grafts and bone graft substitute devices in bone regeneration10.1016/j.msec.2021.112466 ↗
37. Chemically modified RNA activated matrices enhance bone regeneration10.1016/j.jconrel.2015.09.050 ↗
38. BMP-2 mRNA-transfected BMSCs promote superior calvarial bone regeneration10.1038/s41598-025-99979-6 ↗
39. A Comparative Study of the Bone Regenerative Effect of Chemically Modified RNA Encoding BMP-2 or BMP-910.1208/s12248-016-0034-8 ↗
40. Chemically modified RNA induces osteogenesis of stem cells and human tissue explants as well as accelerates bone healing in rats10.1016/j.biomaterials.2016.02.018 ↗
41. Transcript-activated collagen matrix as sustained mRNA delivery system for bone regeneration10.1016/j.jconrel.2016.08.037 ↗
42. Role of donor and host cells in muscle-derived stem cell-mediated bone repair: Differentiation vs. paracrine effects10.1096/fj.13-247965 ↗
43. BMP-2 and VEGF-A modRNAs in collagen scaffold synergistically drive bone repair through osteogenic and angiogenic pathways10.1038/s42003-020-01606-9 ↗
44. Luo, J., Li, L., Deng, Q., Ji, Z., Wang, C., and Dai, B. (2026). Systemic implications of osteoarthritis: From local degeneration to systemic metabolic Dysregulation. J. Transl. Med., Online ahead of print.10.1186/s12967-026-08277-w ↗
45. Engineered cationic Interleukin-1 receptor antagonist outperforms anakinra at joint retention and preventing IL-1-induced cartilage inflammation10.1016/j.joca.2025.12.018 ↗
46. Golubinskaya, P.A., Ruchko, E.S., Bogomazova, A.N., and Eremeev, A.V. (2026). Cellular Products with Anti-Inflammatory Properties for the Treatment of Cartilage Lesions. Int. J. Mol. Sci., 27.10.3390/ijms27104316 ↗
47. Targeting BMP2 signaling pathway in osteogenesis and osteoarthritis: A path toward safer regenerative therapies10.1016/j.cellsig.2026.112482 ↗
48. Bone marrow mesenchymal stem cells overexpressing FGF-2 loaded onto a decellularized extracellular matrix hydrogel for the treatment of osteoarthritis10.1039/D5BM00920K ↗
49. Leukocyte-rich versus leukocyte-poor platelet-rich plasma for Osteoarthritis: A systematic review10.1016/j.reth.2026.101078 ↗
50. Leukocyte-rich versus leukocyte-poor platelet-rich plasma and hyaluronic acid for knee osteoarthritis: A systematic review and network meta-analysis10.1186/s13018-026-06689-4 ↗
51. Messenger RNA delivery of a cartilage-anabolic transcription factor as a disease-modifying strategy for osteoarthritis treatment10.1038/srep18743 ↗
52. Raman spectroscopic insight into osteoarthritic cartilage regeneration by mRNA therapeutics encoding cartilage-anabolic transcription factor Runx110.1016/j.mtbio.2022.100210 ↗
53. Engineered adipose-derived stem cells with IGF-1-modified mRNA ameliorates osteoarthritis development10.1186/s13287-021-02695-x ↗
54. FGF18 encoding circular mRNA-LNP based on glycerolipid engineering of mesenchymal stem cells for efficient amelioration of osteoarthritis10.1039/D4BM00668B ↗
55. Targeted Therapy of Osteoarthritis via Intra-Articular Delivery of Lipid-Nanoparticle-Encapsulated Recombinant Human FGF18 mRNA10.1002/adhm.202400804 ↗
56. Delivery of FGF18 using mRNA-LNP protects the cartilage against degeneration via alleviating chondrocyte senescence10.1186/s12951-025-03103-9 ↗
57. Local delivery of TGF-beta1-mRNA decreases fibrosis in osteochondral defects